These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 7139596)
1. Response of aerobic and hypoxic cells in a solid tumor to adriamycin and cyclophosphamide and interaction of the drugs with radiation. Tannock I Cancer Res; 1982 Dec; 42(12):4921-6. PubMed ID: 7139596 [TBL] [Abstract][Full Text] [Related]
2. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo. Rauth AM; Mohindra JK; Tannock IF Cancer Res; 1983 Sep; 43(9):4154-8. PubMed ID: 6409398 [TBL] [Abstract][Full Text] [Related]
3. Toxicity of aziridinylbenzoquinone for aerobic and hypoxic cells of a transplanted mouse mammary tumor and interaction of the drug with radiation and adriamycin. Tannock I Cancer Res; 1983 May; 43(5):2059-62. PubMed ID: 6831436 [TBL] [Abstract][Full Text] [Related]
4. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide. Milas L; Ito H; Hunter N Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells. Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533 [TBL] [Abstract][Full Text] [Related]
6. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin. Sun JR; Brown JM Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067 [TBL] [Abstract][Full Text] [Related]
7. Interaction of platinum(II) tetrachlorodianion (Fast Black)2 with superhelical DNA and with radiation in vitro and in vivo. Teicher BA; Herman TS; Kaufmann ME Radiat Res; 1989 Jul; 119(1):134-44. PubMed ID: 2756104 [TBL] [Abstract][Full Text] [Related]
8. Effects of endocrine regulation of growth of a mouse mammary tumor on its sensitivity to chemotherapy. Emerman JT; Siemiatkowski J Cancer Res; 1984 Apr; 44(4):1327-32. PubMed ID: 6704951 [TBL] [Abstract][Full Text] [Related]
9. Protection by S-2-(3-aminopropylamino)ethylphosphorothioic acid against radiation- and cyclophosphamide-induced attenuation in antitumor resistance. Milas L; McBride WH; Hunter N; Ito H Cancer Res; 1984 Jun; 44(6):2382-6. PubMed ID: 6327014 [TBL] [Abstract][Full Text] [Related]
10. Effect of methylprednisolone on the cell kinetic response of C3H/HeJ mammary tumors to cyclophosphamide and adriamycin. Braunschweiger PG; Schiffer LM Cancer Res; 1979 Oct; 39(10):3812-5. PubMed ID: 476617 [TBL] [Abstract][Full Text] [Related]
11. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro. Mulcahy RT; Dembs N Cancer Res; 1983 Aug; 43(8):3539-43. PubMed ID: 6861127 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity of hypoxic cell sensitizers in multicell spheroids. Sutherland RM; Bareham BJ; Reich KA Cancer Clin Trials; 1980; 3(1):73-83. PubMed ID: 7389039 [TBL] [Abstract][Full Text] [Related]
13. The response of hypoxic B16 melanoma cells to in vivo treatment with chemotherapeutic agents. Hill RP; Stanley JA Cancer Res; 1975 May; 35(5):1147-53. PubMed ID: 1120304 [TBL] [Abstract][Full Text] [Related]
14. Modification of the metabolism and cytotoxicity of bioreductive alkylating agents by dicoumarol in aerobic and hypoxic murine tumor cells. Keyes SR; Rockwell S; Sartorelli AC Cancer Res; 1989 Jun; 49(12):3310-3. PubMed ID: 2470504 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Chapman JD; Baer K; Lee J Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401 [TBL] [Abstract][Full Text] [Related]
16. Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Lee CG; Heijn M; di Tomaso E; Griffon-Etienne G; Ancukiewicz M; Koike C; Park KR; Ferrara N; Jain RK; Suit HD; Boucher Y Cancer Res; 2000 Oct; 60(19):5565-70. PubMed ID: 11034104 [TBL] [Abstract][Full Text] [Related]
17. Some advantages of curing mice bearing a large subcutaneous MOPC-315 tumor with a low dose rather than a high dose of cyclophosphamide. Mokyr MB; Dray S Cancer Res; 1983 Jul; 43(7):3112-9. PubMed ID: 6850619 [TBL] [Abstract][Full Text] [Related]
18. Toxicity of diethylaminoreserpine to a transplantable tumor: the significance of the presence of hypoxic cells. Lehnert S Cancer Res; 1982 Aug; 42(8):3028-32. PubMed ID: 7093951 [TBL] [Abstract][Full Text] [Related]
19. Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor. Lew YS; Kolozsvary A; Brown SL; Kim JH Cancer Res; 2002 Aug; 62(15):4202-5. PubMed ID: 12154019 [TBL] [Abstract][Full Text] [Related]
20. Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Yokoyama M; Okano T; Sakurai Y; Ekimoto H; Shibazaki C; Kataoka K Cancer Res; 1991 Jun; 51(12):3229-36. PubMed ID: 2039998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]